High-flying biotech Intercept Pharmaceuticals (ICPT +0.00%) enjoyed a 516% gain last week, but shares have tumbled this week. After yesterday's 18% dive, shares dropped another 30% today. In the following video, analyst Max Macaluso discusses what caused today's drop and the key issues that long-term investors need to focus on.
Why Biotech Boomer Intercept Pharmaceuticals, Inc. Tumbled Again
By Max Macaluso – Jan 14, 2014 at 8:04PM
NASDAQ: ICPT
Intercept Pharmaceuticals
Why did Intercept shares tumble today?
About the Author
Max is the Technology, Biopharma & Health Care Bureau Chief at Fool.com. Prior to joining the Fool, he completed a PhD in chemistry at the University of Cambridge and an MBA at the College des Ingenieurs.
Follow @TMFMassimo